Business profile

SL.Pharma Oy

SL.Pharma Oy's registered office is Helsingfors. It is a limited company. The company was established on 2019-09-16. It operates in the industry of other human health activities n.e.c.. In its latest retained statement for 2025-12-31, revenue was €1,323,491 and operating profit was €331,171.

Claim profileContact details
Business ID 3085704-8ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3085704-8
Sector
Other human health activities n.e.c.
Municipality
Helsingfors
Company form
Limited company
Registration date
2019-09-16
Business ID registration date
2019-09-09
Business status
Valid
Profile ownership
Unclaimed company profile
Data source
Public registry data

Contact and location summary

Visiting address: Ulvilantie 10 B 9, 00350, Helsingfors

About SL.Pharma Oy

Financial position and key figures for the company.

SL.Pharma Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2019-09-16. It operates in the industry of other human health activities n.e.c.. In its latest retained statement for 2025-12-31, revenue was €1,323,491 and operating profit was €331,171. The latest retained financial statement for 2025-12-31 shows revenue of €1,323,491 and profit for the financial year of €263,496. Based on the latest retained statement, revenue growth was +7.9%, operating margin was +25.0%, and equity ratio was +93.3%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods4
PRH parsed2
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth7.9%
Operating margin25.0%
Equity ratio93.3%
Balance-sheet contextLatest retained period snapshot
Other operating income€39,705Previous: €45,996
Inventory€185,676Previous: €199,424
Cash and bank€306,253Previous: €250,600
Retained earnings€808,495Previous: €651,510
Equity€1,071,991Previous: €878,745
Liabilities€77,347Previous: €77,541
Current assets€766,794Previous: €846,228
Current liabilities€77,347Previous: €77,541
Revenue trend2 periods
€1,226,094
2024-12-31
€1,323,491
2025-12-31
Operating profit (loss) trend2 periods
€290,631
2024-12-31
€331,171
2025-12-31
Profit (loss) for the financial year trend2 periods
€227,235
2024-12-31
€263,496
2025-12-31
Assets trend2 periods
€956,286
2024-12-31
€1,149,338
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
93.3 %2024-12-31: 91.9 %
Current ratioGood
100/100 · Improving
6.36x2024-12-31: 5.80x
Operating profit marginGood
100/100 · Improving
24.3 %2024-12-31: 22.9 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio91.9 %93.3 %
Current ratio5.80x6.36x
Operating profit margin22.9 %24.3 %

Registry status and identifiers

Verified registry memberships and identifiers from the latest retained YTJ snapshot.

YTJ statusValid
Trade RegisterRegistered
Business ID3085704-8
VAT IDFI30857048
EU IDFIFPRO.3085704-8
MunicipalityHelsingfors
Current registered entries
2019-09-09Registered in Tax Administration (Prepayment Register)
2019-09-16Registered in Tax Administration (Tax Administration)
2019-09-16Registered in Patent and Registration Office (Trade Register)
2019-10-01VAT-liable for business activity in Tax Administration (VAT Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Financial data includedNot a credit decision
A1
ExcellentSL.Pharma Oy
Updated2026-08-24
ConfidenceHigh
Score90/100

The grade can use open digital financial statement data together with registry signals.

Risk context

When open digital financial statements are unavailable, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
92/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 6 years of registry continuity.

Registry and status signalsSeurattava
64/100

Registry history, filing recency, and active register markings are still limited or mixed.

Registry timeline

Trade register notifications shown on a timeline.

10 register eventsLatest event: 2026-04-28

Financial statements availability

Available statement periods and links into the retained/parsible financial statement surfaces. Use the latest statement page for deeper line-item detail.

4 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

SL.Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.